Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 48NIH 4OTHER_GOV 3NETWORK 2INDUSTRY 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 2Breast 2

Conditions

Breast Neoplasms 265Breast Neoplasms, Male 20Breast Carcinoma In Situ 15Carcinoma, Non-Small-Cell Lung 13Prostatic Neoplasms 12Carcinoma, Intraductal, Noninfiltrating 12Neoplasm Metastasis 11Lung Neoplasms 11Carcinoma, Ductal, Breast 11Pain 9Colorectal Neoplasms 9Colonic Neoplasms 9Neoplasms 8Inflammatory Breast Neoplasms 8Osteoporosis 7Carcinoma, Ovarian Epithelial 7Triple Negative Breast Neoplasms 6Ovarian Neoplasms 6Fatigue 6Small Cell Lung Carcinoma 5Rectal Neoplasms 5Testicular Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Sezary Syndrome 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Mycosis Fungoides 4Multiple Myeloma 4Melanoma 4Lymphoma, T-Cell, Cutaneous 4

Interventions

Zoledronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Hereditary Breast and Ovarian Cancer Syndrome × Breast × Clear all
NCT01445275 2024-08-21

Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199

GOG Foundation

Withdrawn
BreastGynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

NCT00305695 2020-03-24

Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries

GOG Foundation

Phase 2 Completed
160 enrolled 10 charts
BreastGynecologic

Osteoporosis, Ovarian Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡